Comparing Lancer Orthodontics (OTCMKTS:LANZ) & Pro-Dex (NASDAQ:PDEX)

Pro-Dex (NASDAQ:PDEX) and Lancer Orthodontics (OTCMKTS:LANZ) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

Profitability

This table compares Pro-Dex and Lancer Orthodontics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pro-Dex	13.48%	26.67%	14.95%
Lancer Orthodontics	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and target prices for Pro-Dex and Lancer Orthodontics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0	1	1	0	2.50
Lancer Orthodontics	0	0	0	0	0.00

Pro-Dex currently has a consensus target price of $56.00, suggesting a potential upside of 64.56%. Given Pro-Dex’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Pro-Dex is more favorable than Lancer Orthodontics.

Institutional & Insider Ownership

15.3% of Pro-Dex shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 24.3% of Lancer Orthodontics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Pro-Dex has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Comparatively, Lancer Orthodontics has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

Earnings and Valuation

This table compares Pro-Dex and Lancer Orthodontics”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59 million	1.67	$8.98 million	$2.70	12.60
Lancer Orthodontics	N/A	N/A	N/A	N/A	N/A

Pro-Dex has higher revenue and earnings than Lancer Orthodontics.

Summary

Pro-Dex beats Lancer Orthodontics on 9 of the 10 factors compared between the two stocks.

About Pro-Dex

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

About Lancer Orthodontics

Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. The company was founded in 1967 and is based in Vista, California.